Aktie A1W93M HUMAN METABOLOME TECHNOLOGIES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Human Metabolome Technologies, Inc.

Aktien

A1W93M

JP3794530000

6090

Markt geschlossen - Japan Exchange
Andere Börsenplätze
 08:00:00 09.05.2024 		% 5 Tage % 1. Jan.
641 JPY -0.62% Intraday Chart für Human Metabolome Technologies, Inc. -0.62% +0.16%
14.02. Human Metabolome Technologies, Inc. gibt eine Dividendenprognose für das Jahr bis Juni 2024 ab CI
2023 Human Metabolome Technologies, Inc. gibt eine konsolidierte Gewinnprognose für das Jahr bis zum 30. Juni 2024 ab CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Human Metabolome Technologies, Inc. Provides Dividend Guidance for the Year Ending June 2024
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024
Human Metabolome Technologies, Inc. Announces Year End Dividend for the Year Ended June 30, 2023, Payable on September 7, 2023; Provides Year End Dividend Guidance for the Year Ending June 30, 2024
Human Metabolome Technologies, Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 2023
Human Metabolome Technologies, Inc. Provides Dividend Guidance for the Year Ending June 2023
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 30, 2023
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 2023
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 2023
Human Metabolome Technologies, Inc. Provides Earnings Guidance for the Full Year Ending June 2022
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022
Human Metabolome Technologies : Summary of Financial Results 2021
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Fourth Quarter Ended June 2021
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022
Human Metabolome Technologies : Summary of Financial Results for the third quarter 2021
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Third Quarter Ended March 2021
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Second Quarter Ended December 2020
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2021
Human Metabolome Technologies, Inc. Announces Financial Results for the Quarter Ended September 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1W93M Aktie
  4. Nachrichten Human Metabolome Technologies, Inc.
  5. Andere Sprachen